Skip to main content

Table 1 Analyses of mRNA levels of fecal KIAA0247 in clinical features

From: A predicted protein, KIAA0247, is a cell cycle modulator in colorectal cancer cells under 5-FU treatment

Featuresa n b Cases with higher mRNA
levels of fecal KIAA0247
(>0.4897)
p-valuec
Age (years)     
  ≤ 66.0 27 11 (40.7%) 0.874
  >66.0 28 12 (42.9%)  
Gender     
  Male 37 14 (37.8%) 0.290
  Female 19 10 (52.6%)  
Dukes' stages     
  A+B 28 14 (50.0%) 0.210
  C+D 27 9 (33.3%)  
Depth of invasion     
  T1+T2 24 14 (58.3%) 0.053
  T3+T4 31 10 (32.3%)  
Lymphatic invasion     
  N0 32 15 (46.9%) 0.568
  N1+N2+N3 23 9 (39.1%)  
Distant metastasis     
  No 34 18 (52.9%) 0.058
  Yes 22 6 (27.3%)  
Tumor location     
  Right 20 6 (30.0%)  
  Left 13 6 (46.2%) 0.341
  Rectum 19 10 (52.6%)  
CEA (ng/ml)     
  ≤ 5 28 15 (53.6%) 0.072
  >5 27 8 (29.6%)  
CA19-9 (U/ml)     
  <37 34 15 (44.1%) 0.371
  ≥ 37 19 6 (31.6%)  
Differentiation     
  Well/moderate 47 22 (46.8%) 0.065
  Poor 5 0 (0%)  
  1. a Median age, 66 years; age range, 40.3-89.5 years; CEA, carcinoembryonic antign; CA19-9, carbohydrate antigen 19-9.
  2. b Numbers of assessed cases are dependent on the available cases.